Statistics in medical journals: Some recent trends

Statistics in Medicine

Volumn 19, Issue 23, 2000, Pages 3275-3289

  Altman, Douglas G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTER ANALYSIS; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HYPOTHESIS; MEDICAL LITERATURE; MEDICAL RESEARCH; REVIEW; STATISTICAL ANALYSIS; STATISTICS;

DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; PERIODICALS; RANDOMIZED CONTROLLED TRIALS; REVIEW LITERATURE; STATISTICS;

EID: 0034672380     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M     Document Type: Review

References (106)

1. Primary, secondary, and meta-analysis of research
2. Meta-analysis of the effects of stuttering treatment
3. Statistics in medical journals: Developments in the 1980s
4. Systematic reviews of published evidence: Miracles or minefields?
5. Random-effects meta-analyses are not always conservative
6. Systematic reviews of trials and other studies
7. Choosing an appropriate dichotomous effect measure for meta-analysis: Empirical evidence of the appropriateness of the odds ratio and relative risk
8. Down with odds ratios!
9. Odds ratios revisited
10. Clinically useful measures of effect in binary analyses of randomized trials
11. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
12. The hazards of scoring the quality of clinical trials for meta-analysis
13. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis
14. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
15. Quality scores are useless and potentially misleading
16. Impact of study quality on outcome of placebo-controlled trials of homeopathy
17. Can meta-analysis be salvaged?
18. Spurious precision? Meta-analysis of observational studies
19. Combining independent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional considerations
20. Estimating diagnostic accuracy from multiple conflicting reports: A new meta-analytic method
21. Meta-analytic methods for diagnostic test accuracy
22. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
23. Empirical evidence of design-related bias in studies of diagnostic tests
24. Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: A meta-meta-analysis
25. In the teeth of the evidence: The curious case of evidence-based medicine
26. An assessment of clinically useful measures of the consequences of treatment
27. Confidence intervals for the number needed to treat
28. Number needed to screen: Development of a statistic for disease screening
29. Numbers needed to treat derived from meta-analyses - Sometimes informative, usually misleading
30. Why we need observational studies to evaluate the effectiveness of health care
31. Measuring effects without randomized trials? Options, problems, challenges
32. The unpredictability paradox: Review of empirical comparisons of randomised and non-randomised clinical trials
33. Choosing between randomised and non-randomised studies: A systematic review
34. Comparisons of effect sizes derived from randomised and non-randomised studies
35. Using observational data from registries to compare treatments: The fallacy of omnimetrics
36. Centre for Evidence-Based Medicine. Levels of evidence and grades of recommendations
37. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions
38. Some aspects of the design and analysis of cluster randomization trials
39. Trials which randomize practices I: How should they be analysed
40. Trials which randomize practices II: Sample size
41. Simple sample size calculation for cluster-randomized trials
42. Ethical issues in the design and conduct of cluster randomised controlled trials
43. Statistical issues in the design and analysis of cluster randomized trials
44. A methodological review of non-therapeutic intervention trials employing cluster randomization, 1979-1989
45. Accounting for cluster randomization: A review of primary prevention trials, 1990 through 1993
46. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
47. Transfer of technology from statistical journals to the biomedical literature: Past trends and future predictions
48. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology
49. Some misuses of discriminant analysis
50. Reliability of league tables of in vitro fertilisation clinics: Retrospective analysis of live birth rates
51. Sponsored drug trials show more-favourable outcomes
52. Interaction 2: Compare effect sizes not P values
53. Interaction 3: How to examine heterogeneity
54. Sponsored trials do not necessarily give more-favourable results
55. The cost of dichotomization
56. Two issues concerning the analysis of grouped data
57. A study of the effect of dichotomizing ordinal data upon modelling
58. Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors
59. Suboptimal analysis using 'optimal' cutpoints
60. Defining exposure in case-control studies: A new approach
61. Controlling for continuous confounders in epidemiologic research
62. Dose-response and trend analysis in epidemiology: Alternatives to categorical analysis
63. Should we have confidence intervals in radiology papers?
64. Fundamental concepts in statistics: Elucidation and illustration
65. Statistical significance testing in the American Journal of Epidemiology, 1970-1990
66. A show of confidence
67. Writing for Epidemiology
68. Multiple comparisons, explained
69. No adjustments are needed for multiple comparisons
70. What's wrong with Bonferroni adjustments
71. P-value interpretation and alpha allocation in clinical trials
72. Quantitative evaluation of multiplicity in epidemiology and public health research
73. Biostatistics and Bayes
74. An introduction to Bayesian methods in health technology assessment
75. Towards evidence-based medical statistics. Part 2. The Bayes factor
76. Absence of evidence is not evidence of absence
77. Absence of evidence is not evidence of absence
78. Uniform requirements for manuscripts submitted to biomedical journals
79. Multistage designs for phase II clinical trials: Statistical issues in cancer research
80. Logistic regression models used in medical research are poorly presented
81. Methodological quality of randomized clinical trials on treatment efficacy in low back pain
82. A retrospective quality analysis of 102 randomized trials in four leading urological journals from 1984-1989
83. A critical review of papers from clinical cancer research
84. Content and quality of 2000 controlled trials in schizophrenia over 50 years
85. Methodologic standards in surgical trials
86. Putting trials on trial - The costs and consequences of small trials in depression: A systematic review of methodology
87. What is meant by intention to treat analysis? Survey of published randomised controlled trials
88. Improving the quality of reporting of randomized controlled trials: The CONSORT Statement
89. CONSORT: An evolving tool to help improve the quality of reports of randomized controlled trials
90. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement
91. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests
92. Low power, type II errors, and other statistical problems in recent cardiovascular research
93. Statistics in medical journals
94. Accuracy of statistical methods in TRANSFUSION: A review of articles from July/August 1992 through June 1993
95. The use of statistics in the British Journal of Psychiatry
96. Review of statistics usage in the American Journal of Obstetrics and Gynecology
97. Statistics in articles published in TRANSFUSION
98. Statistics usage in the American Journal of Obstetrics and Gynecology: Toward a better understanding
99. Improving the quality of statistics in psychiatric research
100. Statistical errors in papers in the British Journal of Psychiatry
101. Reliability of assessment tools in rehabilitation: An illustration of appropriate statistical analyses
102. Observational reserarch and evidence-based medicine: What should we teach young physicians?
103. The scandal of poor medical research